ѰҽÎÊÒ©Íø > 2ÐÍÌÇÄò²¡ºÏ²¢ÄÔѪ˨ÐγÉΣÏÕÒòËØ·ÖÎö

2ÐÍÌÇÄò²¡ºÏ²¢ÄÔѪ˨ÐγÉΣÏÕÒòËØ·ÖÎö

ÎÄ·¢²¼Õߣº
À´Ô´£ºÑ°Ò½ÎÊÒ©Íø
     ×÷Õߣº³Â·ïÁá ËÎÎÄÓ¢

    µ¥Î»£º³Â·ïÁá(°ö²ºÒ½Ñ§Ôº¸½ÊôÒ½Ôº ÀÏÄ겡¿Æ£¬°²»Õ °ö²º 233004)£»ËÎÎÄÓ¢(°ö²ºÒ½Ñ§Ôº¸½ÊôÒ½Ôº ÀÏÄ겡¿Æ£¬°²»Õ °ö²º 233004)

    ¹Ø¼ü´Ê£ºÌÇÄò²¡£»ÄÔ˨ÈûºÍѪ˨Ðγɣ»¸ÅÂÊ

    °ö²ºÒ½Ñ§ÔºÑ§±¨000512 [ÕªÒª] Ä¿µÄ£º·ÖÎö2ÐÍÌÇÄò²¡ºÏ²¢ÄÔѪ˨ÐγɵÄΣÏÕÒòËØ¡£·½·¨£ºÓ¦ÓöàÒòËØLogistic»Ø¹é·ÖÎö109Àý2ÐÍÌÇÄò²¡»¼ÕßÓйØÄÔѪ˨ÐγɵÄÏà¹ØÎ£ÏÕÒòËØ¡£½á¹û£º2ÐÍÌÇÄò²¡ºÏ²¢ÄÔѪ˨ÐγÉÕ¼30.28%£»ÌÇÄò²¡²¡³Ì¡¢ÌåÖØÖ¸Êý¡¢¿Õ¸¹ÑªÌÇ¡¢ÔØÖ¬µ°°×BµÈÒòËØÓë2ÐÍÌÇÄò²¡»¼ÕßµÄÄÔѪ˨ÐγÉÓйء£½áÂÛ£º2ÐÍÌÇÄò²¡»¼ÕßӦעÒâ¿ØÖÆÑªÌÇ¡¢ÌåÖØ¼°ÑªÖ¬£¬ÒÔÔ¤·ÀÄÔѪ˨Ðγɡ£

    [ÖйúͼÊé×ÊÁÏ·ÖÀà·¨·ÖÀàºÅ] R 587.1£»R 743.32 [ÎÄÏ×±êʶÂë] A

    [ÎÄÕ±àºÅ] 1000-2200(2000)05-0336-02

    Risk factors for cerebral thrombosis in type 2 diabetes mellitus

    CHEN Feng-lin£¬SONG Wen-yin

    (Department of Geriatrics,Affiliated Hospital of Bengbu Medical College,Anhui 233004,China)

    [Abstract] Objective:To analyse the risk factors for cerebral thrombosis in patients with type 2 diabetes.Methods:One hundred and nine type 2 diabetic patients were analysed with multiple Logistic regression.Results:Incidence of cerebral thrombosis was 30.28% in type 2 diabetics.Duration of Dm,BMI,fasting serum of glucose,ApoB were correlated with cerebral thrombosis in type 2 diabetic patients.Conclusions:Controling serum glucose,weight and serum fat is crucial to the prevention cerebral thrombosis for patients with type 2 diabetic mellitus.

    [Key words] diabetes mellitus;cerebral embolism and thrombosis;probability

    ÌÇÄò²¡µÄ»¼²¡ÂÊÔÚÎÒ¹úÓÐÖðÄêÉÏÉýµÄÇ÷ÊÆ£¬ÄÔѪ˨ÐγÉÊÇÆä³£¼û²¢·¢Ö¢¡£ÌÇÄò²¡ÄÔѪ˨Ðγɵķ¢²¡Âʱ¨µÀÉõÉÙ£¬¹úÄÚÎÄÏ×·ÖÎöÔÚÄÔ¹£ËÀÖУ¬ÌÇÄò²¡»¼ÕßÊÇ·ÇÌÇÄò²¡»¼ÕßµÄ2±¶[1]£»¶øÌÇÄò²¡ºÏ²¢ÄÔѪ˨ÐγɵIJ¡ËÀÂʸßÓÚ·ÇÌÇÄò²¡»¼ÕßÄÔѪ˨Ðγɲ¡ËÀÂʵÄ12%[2]¡£Ä¿Ç°ÆÕ±éÈÏΪ£¬ÌÇÄò²¡ºÏ²¢ÄÔѪ˨ÐγɿÉÄÜÊǶàÖÖÒòËØ×ÛºÏ×÷ÓõĽá¹û¡£ÎªÁË̽ÌÖÌÇÄò²¡ºÏ²¢ÄÔѪ˨ÐγɵÄΣÏÕÒòËØ£¬±¾ÎĶÔסԺµÄ109ÀýÌÇÄò²¡»¼Õß½øÐжàÒòËØ·ÖÎö¡£

    1 ×ÊÁÏÓë·½·¨

    1.1 Ò»°ã×ÊÁÏ 1995¡«1998Ä꣬ÎÒÔº°´WHO±ê×¼Õï¶ÏµÄ2ÐÍÌÇÄò²¡109Àý¡£ÄÐ79Àý£¬Å®30Àý£»ÄêÁä52¡«74Ëê¡£ÌÇÄò²¡²¡³Ì5¡«16Äê¡£°´1986ÄêÈ«¹úµÚ¶þ´ÎÄÔѪ¹Ü¼²²¡»áÒéͨ¹ýµÄÕï¶Ï±ê×¼£¬ÆäÖÐ33ÀýºÏ²¢ÄÔѪ˨Ðγɣ»ÄÐ23Àý£¬Å®10Àý£»ÄÔѪ˨ÐγÉÕ¼30.28%¡£

    1.2 ·½·¨ ²â¶¨ÑªÑ¹(È¡²»Í¬ÈÕ3´ÎѪѹµÄ¾ùÖµ£¬·Ö±ðÓиßѪѹ»òÎÞ¸ßѪѹÁ½ÖÖ)£¬ÌåÖØÖ¸Êý[BMI=ÌåÖØ/Éí¸ß2(kg/m2)]¡£ÌÇÄò²¡²¡³Ì°´´ÓÃ÷È·Õï¶Ï¿ªÊ¼»ò´Ó³öÏÖÃ÷ÏԵġ°Èý¶àÒ»ÉÙ¡±Ö¢×´µ½ÄÔ¹£ËÀ·¢²¡¡£ÎÞÄÔ¹£ËÀ»¼Õß´ÓÃ÷È·Õï¶Ï»ò´Ó³öÏÖÃ÷ÏԵġ°Èý¶àÒ»ÉÙ¡±Ö¢×´¿ªÊ¼µ½ÈëԺʱ¡£¿Õ¸¹ÑªÌDzͺó2 hѪÌÇ(ÄÔ¹£ËÀ»¼ÕßΪÅųýÓ¦¼¤ÒòËØÓ°Ï죬ȡÔÚ·¢²¡2ÖܺóµÄ¿Õ¸¹ÑªÌǺͲͺóѪÌÇ£¬·ÇÄÔ¹£ËÀ»¼ÕßÈ¡ÈëԺʱµÄ¿Õ¸¹ÑªÌǺͲͺó2 hѪÌÇ)¡¢ÑªÇå×ܵ¨¹Ì´¼(TC)¡¢¸ÊÓÍÈýõ¥(TG)¡¢ÔØÖ¬µ°°×A(ApoA)¡¢ÔØÖ¬µ°°×B(ApoB)¡¢ÑªÇåÄòËá(UA)¡£

    1.3 ͳ¼ÆÑ§·½·¨ ²ÉÓÃt¡¢¦Ö2¼ìÑéºÍ¶àÒòËØ·ÖÎöÓÃLogistic»Ø¹é·¨¡£

    2 ½á¹û

    2.1 ²âÁ¿Ö¸±ê ÌÇÄò²¡ÄÔѪ˨ÐγÉ×éÓë·ÇÄÔѪ˨ÐγÉ×éµÄÁÙ´²×ÊÁϼ°¸÷Ïî²âÁ¿Ö¸±ê½á¹û¼û±í1¡£

    2.2 ¶àÒòËØ·ÖÎö ÐÔ±ð¡¢ÄêÁä¡¢ÌÇÄò²¡²¡³Ì¡¢¸ßѪѹ¡¢BMI¡¢FSG¡¢²Íºó2 h SG¡¢TC¡¢TG¡¢ApoA,ApoB¡¢UAµÈ12¸öÖ¸±êÖÐɸѡ³ö4¸öÒòËØ¡£½á¹û¼û±í2¡£

    3 ÌÖÂÛ

    ÌÇÄò²¡Ñª¹Ü²¡±ä·Ç³£¹ã·º£¬²»ÂÛ´óÖÐС¶¯Âö¡¢Ã«Ï¸Ñª¹Ü»ò¾²Âö¾ù¿ÉÀÛ¼°£¬ÌÇÄò²¡ÐÔÄÔѪ¹Ü²¡±äÓë·ÇÌÇÄò²¡ÐÔÄÔѪ¹Ü²¡µÄÁÙ´²±íÏÖÀàÐÍÎÞÌØÒìÐÔ²î±ð¡£ÌÇÄò²¡ÊÇÔì³É¶à·¢ÐÔǻ϶ÐÔÄÔ¹£ËÀµÄ¶ÀÁ¢µÄ¾ßÓоö¶¨ÐÔµÄÒòËØ[3]¡£ÆÕͨÈËȺµÄÑо¿±íÃ÷£¬ÑªTC¡¢SG¡¢¸ßÒȵºËØÑªÖ¢¡¢ApoB¡¢TGµÈÒòËØÓëÄÔѪ˨ÐγÉÓÐÏà¹ØÐÔ[4]¡£±¾Ñо¿²ÉÓöàÒòËØ·ÖÎö£¬´Ó12¸öÒòËØÖÐɸѡ³öÓë2ÐÍÌÇÄò²¡ÄÔѪ˨ÐγɿÉÄÜÏà¹ØµÄ4¸öÒòËØ£ºÌÇÄò²¡²¡³Ì¡¢BMI¡¢FSG¡¢ApoB¡£

    ±í1 Á½×黼ÕßÁÙ´²×ÊÁϺ͸÷ÏîÖ¸±ê±È½Ï(¡Às) ·Ö×é

    n

    ÐÔ±ð

    ¸ß

    ÑªÑ¹

    ÄêÁä

    (Ëê)

    ²¡³Ì

    (Äê)

    ÌåÖØÖ¸Êý

    (kg/m2)

    ÑªÌÇ(mmol/L)

    TC

    (mmol/L)

    TG

    (mmol/L)

    Apo(g/L)

    UA

    (¦Ìmol/L)

    ÄÐ

    Å®

    ¿Õ¸¹

    ²Íºó

    A

    B

    ÄÔѪ˨ÐγÉ×é

    33

    10

    23

    16

    67.67¡À4.71

    9.06¡À2.87

    24.90¡À1.41

    8.1¡À0.90

    13.56¡À1.57

    5.47¡À0.39

    2.26¡À0.32

    1.16¡À0.09

    1.23¡À0.04

    371.3¡À71.7

    ·ÇÄÔѪ˨ÐγÉ×é

    76

    20

    56

    26

    62.76¡À5.77

    7.57¡À1.93

    22.80¡À0.94

    6.9¡À0.99

    11.27¡À1.83

    5.02¡À0.35

    2.00¡À0.34

    1.23¡À0.10

    1.18¡À0.06

    330.8¡À61.3

    t

    ¡ª

    0.18¡÷

    1.98¡÷

    4.29

    3.17

    9.12

    5.96

    6.24

    5.94

    3.72

    3.46

    4.38

    3.01

    P

    ¡ª

    >0.05

    >0.05

    <0.01

    <0.01

    <0.01

    <0.01

    <0.01

    <0.01

    <0.01

    <0.01

    <0.01

    <0.01

    ¡÷ʾÁ½×é±È½ÏµÄ¦Ö2¼ìÑéÖµ±í2 ÌÇÄò²¡ºÏ²¢ÄÔѪ˨ÐγÉLogistic»Ø¹é·ÖÎö ΣÏÕÒòËØ

    Æ«»Ø¹éϵÊý

    P

    ²¡³Ì

    0.709 5

    <0.05

    ÌåÖØÖ¸Êý

    1.883 9

    <0.01

    ¿Õ¸¹ÑªÌÇ

    1.546 0

    <0.05

    ÔØÖ¬µ°°×B

    3.425 0

    <0.01

    ¸ßѪÌǼ°¸ßѪÌdzÖÐøÊ±¼äÓëÄÔѪ˨ÐγɵĹØÏµÕýÔÚ±»ÒýÆð×¢Òâ[5]¡£ÌÇ»¯Ñªºìµ°°×¿ÉÒÔ·´Ó³»úÌå2¡«3ÖÜÄÚµÄѪÌDZ仯¡£ºìϸ°ûµÄ¾Û¼¯ÐÔÓëÌÇ»¯Ñªºìµ°°×³ÊÏÔÖøÕýÏà¹Ø[6]¡£ÌÇÄò²¡¸ßѪÌÇÒýÆðȫѪճ¶ÈÏÔÖøÉý¸ß£¬Ìáʾ¸ßѪÌÇʱºìϸ°û¾Û¼¯ÐÔÔöÇ¿£¬´ËÓë¸ßѪÌÇ×÷ÓÃʱ¼ä³¤¶Ì¼°ÓÐÎÞѪ¹Ü²¡Àí¸Ä±äÓйØ[5]£»¸ßѪÌÇʱÀÏ»¯ºìϸ°ûÔö¶à£¬¾Û¼¯ÐÔÔöÇ¿£¬´àÐÔÔö¼Ó£¬Ñ­»·ÑªÁ÷»ºÂý£¬ºìϸ°ûÓÙ»ý¡¢ËéÁÑÒýÆðÄÔѪ˨Ðγɡ¢ÄÔ¹£ËÀÃæ»ýÀ©´ó[6]¡£±¾Ñо¿½á¹ûÒàÌáʾ£¬FSGÉý¸ß¼°ÌÇÄò²¡»¼Õß²¡³ÌÓëÄÔѪ˨ÐγÉÏà¹Ø¡£

    2ÐÍÌÇÄò²¡»¼Õß¶à°éÓÐÖ¬´úлÎÉÂÒ£¬Ö÷Òª±íÏÖΪTGÉý¸ß£¬ApoBÉý¸ßÓëÌÇÄò²¡²¢·¢ÄÔѪ˨ÐγÉÏà¹ØÁª¡£¸ßApoBѪ֢¿ÉÄÜÊÇ2ÐÍÌÇÄò²¡²¢·¢ÄÔѪ˨ÐγɵÄΣÏÕÒò×Ó¡£ÆÕͨÈËȺÑо¿Ìáʾ£¬ÑªÇåApoBˮƽÊÇȱѪÐÔÄÔѪ¹Ü²¡µÄÒ»¸öÖØÒªÎ£ÏÕÒòËØ[7]¡£µ«Æä×÷ÓÃÈÔ¿ÉÄÜÊÇͨ¹ýÓ°Ï쵨¹Ì´¼ºÍTGµÄ´úл;¾¶¶øÊµÏֵġ£ÍõÀÚµÈ[8]±¨µÀÔÚÄÔ¹£ËÀ·¢²¡µÄ²»Í¬½×¶Î¾ù°éÓиßApoB,¸ßTG¡£

    Ñо¿Öл¹¹Û²ìµ½BMIÊÇ2ÐÍÌÇÄò²¡ºÏ²¢ÄÔѪ˨ÐγɵÄΣÏÕÒòËØ£»¿ÉÄܵÄÔ­ÒòÊÇ·ÊÅÖµÄ2ÐÍÌÇÄò²¡»¼Õ߸ßÒȵºËØÑªÖ¢ºÍÒȵºËصֿ¹¸ü¼ÓÑÏÖØ¡£½üÄêµÄÑо¿±íÃ÷£¬»úÌåµÄÒȵºËصֿ¹×´Ì¬Ó붯ÂöÖàÑùÓ²»¯¼°ÄÔѪ˨ÐγÉÓÐÃÜÇйØÏµ¡£ShinozakiµÈ[9]Ò²ÈÏΪ£¬ÒȵºËصֿ¹»¼ÕßÍùÍù°éÓÐÖ¬´úлÎÉÂÒ£¬¼´TG¡¢ApoBµÄÔö¸ßºÍApoAµÄ½µµÍÓëȱѪÐÔÄÔ×äÖÐÓÐÏà¹ØÐÔ£»¶øÍõÀÚµÈ[8]Ñо¿ÔòÈÏΪÒȵºËصֿ¹ÊÇȱѪÐÔÄÔѪ˨µÄÒ»¸ö¶ÀÁ¢µÄΣÏÕÒòËØ¡£

    ×÷Õß¼ò½é£º³Â·ïÁá(1967-)£¬Å®£¬°²»Õ·ïÑôÏØÈË£¬Ö÷ÖÎҽʦ.

    [²Î¿¼ÎÄÏ×]

    [1]Ëν¡Æ½£¬Öì»ÛÇÙ£¬Ô¬Àö¾ê£¬µÈ.ÌÇÄò²¡ÑªÌÇˮƽ¶ÔÄÔ¹£Èû»¼ÕßÔ¤ºóµÄÓ°Ïì[J].ÁÙ´²Éñ¾­²¡Ñ§ÔÓÖ¾£¬1999£¬12(1)¡Ã38.

    [2]Helgason CM.Blood glucose and stroke[J].Stroke,1998,29(4)¡Ã1 049.

    [3]Msat H£¬Thompson JLP,Lee SH,et al.Hypertension and diabetes mellitus as determinate of multiple infarcts[J].Stroke,1995,26(1)¡Ã30.

    [4]ÁøÌ«ÔÆ.ÒȵºËصֿ¹¡¢¸ß֬Ѫ֢Óë¼±ÐÔȱѪÐÔÄÔ×äÖÐ[J].ÁÙ´²Éñ¾­²¡Ñ§ÔÓÖ¾£¬1999£¬12(1)¡Ã32.

    [5]Ê·ºéÈó£¬ÑîÓñÇ죬ÃÏÕÑË®£¬µÈ.¸ßѪÌÇʱºìϸ°û¾Û¼¯Óë¼±ÐÔÄÔ¹£Èû¹ØÏµµÄÑо¿[J].ÖзçÓëÉñ¾­¼²²¡ÔÓÖ¾£¬1999£¬16(3)¡Ã159.

    [6]Beamer N,Giraud G,Clark W,et al.Diabetes hypertension and erythrocyte aggregation in acute stroke[J].Cerebrovasc Dis,1997,7(1)¡Ã144.

    [7]Àî ÎÀ£¬ÐìÐñÈÕ£¬ÖìÆ½¹â£¬µÈ.ѪÇåÔØÖ¬µ°°×BˮƽÓëÖÐ·ç¹ØÏµµÄÑо¿[J].ÖзçÓëÉñ¾­¼²²¡ÔÓÖ¾£¬1992£¬9(9)¡Ã216.

    [8]Íõ ÀÚ£¬º«ÖÙÑÒ.ÒȵºËصֿ¹¡¢ÑªÖ¬Òì³£ÓëȱѪÐÔÄÔѪ¹Ü¼²²¡µÄ¶¯Ì¬Ñо¿[J].ÁÙ´²Éñ¾­²¡Ñ§ÔÓÖ¾£¬1992£¬12(5)¡Ã271.

    [9]Shinozaki K,Naritomi H,Shimizu T,et al.Role of insulin resistance associated with compensatory hyperinsulinemia in ischemic stroke[J].Stroke,1996,27(1)¡Ã37.

    ÊÕ¸åÈÕÆÚ£º1999-06-30 (ÎÄÕ³ö´¦£º°ö²ºÒ½Ñ§ÔºÑ§±¨ 2000ÄêµÚ5ÆÚµÚ25¾í)
Ïà¹ØÎÊ´ð£º
  • ÌÇÄò²¡ÒýÆðµÄÄÔѪ˨
  • ÄÔѪ˨-ÌÇÄò²¡Ð¡ÄÔίËõ
  • ÌÇÄò²¡ÄÔѪ˨ÏÂθ¹ÜºóµÄÁ÷ʳʳÆ×£¿
  • ÌÇÄò²¡ÄÔѪ˨ÏÂθ¹ÜºóµÄÁ÷ʳʳÆ×
  • 2ÐÍÌÇÄò²¡ÓÃɶҩºÃ
  • 2ÐÍÌÇÄò²¡ÓÃʲôҩ
  • µÃÁ˶¯ÂöÑ׺ϲ¢ÄÔѪ˨
  • µÍѪÌǶÔÓ¤¶ùÓÐʲôΣÏÕ?Äָܻ´Âð?ʲôÊÇ.
  • ÔõÑùÇø±ðÒ»ÐÍÌÇÄò²¡ºÍ¶þÐÍÌÇÄò²¡
  • ÓÐÄÔѪ˨ºÍÌÇÄò²¡ÔÚÉú»îÉÏҪעÒâÐ©Ê²Ã´ÄØ?

  • Ïà¹Ø×ÊѶ£º
  • ÄÔѪ˨ÊÇÔõôÐγɵģ¿
  • ÈÑÉïºÏ²¢ÌÇÄò²¡Î£ÏÕÂð
  • Ö¬·¾ÊÇÌÇÄò²¡×îΣÏÕÒòËØ
  • ÄÔѪ˨Ðγɲ¡Ê·¼°Ö¢×´
  • ¾¿¾¹Ê²Ã´½ÐÄÔѪ˨ÐγÉ
  • ÄÔѪ˨ÐγɵļÒÍ¥´¦Àí
  • ÄÔѪ˨ÐγɵÄÏà¹ØÖªÊ¶
  • ÌÇÄò²¡ÐÔÄÔѪ˨ÓëÄÔ³öѪµÄ¼ø±ð
  • Ö¬·¾¸Î¡ª¡ªÌÇÄò²¡µÄΣÏÕÒòËØ
  • ÌÇÄò²¡¶ñ»¯Î£ÏÕÒòËØÊÇÖ¬·¾
  • ½¡¿µÍ¼Æ×

    ¼²²¡´óÈ«

    [½¡¿µ¹ºÎïºÃÈ¥´¦]½¡¿µÉ̳Ç
    ¾«²ÊÍÆ¼ö